HEMATEX
Dead / Abandoned — Abandoned — failure to respond (as of 11 Nov 2018)
What this means for you
This application is over — abandoned 16 Oct 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87495510
- Mark type
- Stylized text
- Filed
- 19 Jun 2017
- Published for opposition
- 31 Oct 2017
- Abandoned
- 16 Oct 2018
- Attorney of record
- Armando Llorens
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceuticals
Owner
- LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION, Miami, FL, US
- LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION, Miami, FL, US
Prosecution history
- 07 Dec 2018 — UNDELIVERABLE MAIL - NO ACTION TAKEN
- 13 Nov 2018 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 11 Nov 2018 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Apr 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Apr 2018 — NON-FINAL ACTION E-MAILED
- 14 Apr 2018 — SU - NON-FINAL ACTION - WRITTEN
- 04 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Mar 2018 — USE AMENDMENT FILED
- 04 Apr 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Mar 2018 — TEAS STATEMENT OF USE RECEIVED
- 26 Dec 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Oct 2017 — PUBLISHED FOR OPPOSITION
- 11 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER